Chitayat–Moore–Del Bigio syndrome
Chitayat–Moore–Del Bigio Syndrome is a rare genetic disorder characterized by a range of physical and developmental anomalies. The syndrome was first identified and described by Chitayat, Moore, and Del Bigio, who observed a distinct pattern of clinical features among affected individuals. This condition is notable for its complexity and the variety of symptoms that can present, making it a challenging syndrome to diagnose and manage.
Symptoms and Characteristics
The primary features of Chitayat–Moore–Del Bigio Syndrome include developmental delay, neurological abnormalities, and distinctive facial features. Patients may exhibit a delay in reaching developmental milestones, intellectual disability, and various neurological issues such as seizures and hypotonia (reduced muscle tone). The facial characteristics associated with this syndrome can include a prominent forehead, widely spaced eyes (hypertelorism), a flat nasal bridge, and a small jaw (micrognathia).
Genetics
Chitayat–Moore–Del Bigio Syndrome is believed to be caused by genetic mutations; however, the specific genetic basis of the syndrome is not fully understood. It is thought to follow an autosomal recessive pattern of inheritance, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the syndrome.
Diagnosis
Diagnosis of Chitayat–Moore–Del Bigio Syndrome is primarily based on clinical observation and the identification of characteristic symptoms. Genetic testing may be utilized to identify specific mutations and confirm the diagnosis, although the rarity of the syndrome and the lack of comprehensive genetic information can make this challenging.
Management and Treatment
There is no cure for Chitayat–Moore–Del Bigio Syndrome, and treatment is symptomatic and supportive. Management strategies may include physical therapy, occupational therapy, and speech therapy to help individuals achieve their maximum developmental potential. Medications may be prescribed to manage seizures and other medical issues. Early intervention and a multidisciplinary approach are crucial for improving the quality of life for affected individuals.
Prognosis
The prognosis for individuals with Chitayat–Moore–Del Bigio Syndrome varies depending on the severity of symptoms and the presence of associated health issues. With appropriate management and support, individuals with this syndrome can lead fulfilling lives, although they may face significant challenges related to their physical and developmental health.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD